Clinical Study
The Platelet Function Analyzer (PFA-100) as a Screening Tool in Neurosurgery
Table 5
Outcome data (categorical variables).
| Parameter | Non-PFA group | PFA group | OR (95% CI) | P value |
| Transfused patients [n] | | | | | Red cells | 12 | 7 | 0.6 (0.2–1.6) | 0.35 | Plasma | 17 | 16 | 1.0 (0.5–2.2) | 1.0 | Platelets | 2 | 4 | 2.3 (0.4–12.6) | 0.43 | Fibrinogen | 3 | 3 | 1.1 (0.2–5.6) | 1.0 | Patients receiving hemostatic treatment [n] | | | | | Desmopressin | 5 | 13 | 3.2 (1.1–9.2) | 0.045 | Aprotinin | 2 | 5 | 2.8 (0.5–15.0) | 0.14 | Tranexamic acid | 0 | 2 | 5.7 (0.3–119.6) | 0.22 | Clinical data [n] | | | | | Intraoperative bleeding tendency | 4 | 6 | 1.7 (0.5–6.2) | 0.42 | Clinically relevant bleeding complication | 2 | 2 | 1.1 (0.4–2.8) | 1.0 |
|
|